Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Differences between WHO AND CDC early growth measurements in the assessment of Cystic Fibrosis clinical outcomes.

Differences between WHO AND CDC early growth measurements in the assessment of Cystic Fibrosis clinical outcomes.

Resource Type

CF Research News

Authors

Usatin D, Yen EH, McDonald C, Asfour F, Pohl J, Robson J

References

J Cyst Fibros. 2017 Jul;16(4):503-509. doi: 10.1016/j.jcf.2016.12.001

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Forced Expiratory Volume in 1second percent predicted (FEV1(pp)) [3]
Growth standards [4]
Survival [5]
Weight-for-length (WFL) [6]

Date

Sunday, July 16, 2017

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/differences-between-who-and-cdc-early-growth-measurements

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00149R3_FINAL_Usatin_16012017.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=DIFFERENCES%20BETWEEN%20WHO%20AND%20CDC%20EARLY%20GROWTH%20MEASUREMENTS%20IN%20THE%20ASSESSMENT%20OF%20CYSTIC%20FIBROSIS%20CLINICAL%20OUTCOMES [3] https://www.ecfs.eu/research-article-keywords/forced-expiratory-volume-1second-percent-predicted-fev1pp [4] https://www.ecfs.eu/research-article-keywords/growth-standards [5] https://www.ecfs.eu/research-article-keywords/survival [6] https://www.ecfs.eu/research-article-keywords/weight-length-wfl [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines